TY  - GEN
AU  - Pengo,V
AU  - Crippa,L
AU  - Falanga,A
AU  - Finazzi,G
AU  - Marongiu,F
AU  - Moia,M
AU  - Palareti,G
AU  - Poli,D
AU  - Testa,S
AU  - Tiraferri,E
AU  - Tosetto,A
AU  - Tripodi,A
AU  - Siragusa,S
AU  - Manotti,C
TI  - Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results
SN  - 1538-7836
PY  - 2013///0228
KW  - Administration, Oral
KW  - Aged
KW  - Aged, 80 and over
KW  - Anticoagulants
KW  - administration & dosage
KW  - Atrial Fibrillation
KW  - blood
KW  - Benzimidazoles
KW  - Clinical Trials, Phase III as Topic
KW  - Dabigatran
KW  - Evidence-Based Medicine
KW  - Female
KW  - Hemorrhage
KW  - chemically induced
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Morpholines
KW  - Patient Safety
KW  - Preventive Health Services
KW  - Pyrazoles
KW  - Pyridones
KW  - Randomized Controlled Trials as Topic
KW  - Rivaroxaban
KW  - Stroke
KW  - Thiophenes
KW  - Treatment Outcome
KW  - Warfarin
KW  - beta-Alanine
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1111/j.1538-7836.2012.04866.x
ER  -